The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2023
Filed:
Aug. 23, 2022
Applicant:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Inventors:
Daniel J. Sexton, Melrose, MA (US);
Ryan Faucette, Melrose, MA (US);
Assignee:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
B01L 3/00 (2006.01); A61B 5/15 (2006.01); A61B 5/154 (2006.01); C07K 16/40 (2006.01); G01N 33/564 (2006.01); G01N 33/573 (2006.01); G01N 33/96 (2006.01);
U.S. Cl.
CPC ...
B01L 3/5082 (2013.01); A61B 5/15003 (2013.01); A61B 5/154 (2013.01); A61B 5/150755 (2013.01); C07K 16/40 (2013.01); G01N 33/564 (2013.01); G01N 33/573 (2013.01); G01N 33/96 (2013.01); B01L 2200/16 (2013.01); B01L 2300/0832 (2013.01); G01N 2333/96433 (2013.01);
Abstract
Disclosed herein are evacuated blood collection tubes comprising protease inhibitor cocktails in liquid form and uses thereof for assessing features associated with the contact system in a subject, including the endogenous level of contact system activation, the endogenous level of a drug that targets a component of contact system during treatment, and/or the immunogenicity of such a drug.